Trials / Completed

CompletedNCT00991705

A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

An Open-label, Two-treatment, Two-period, Two-sequence, Crossover Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Status: Completed
Phase: Phase 1
Study type: Interventional
Enrollment: 28 (actual)

Sponsor: Boryung Pharmaceutical Co., Ltd · Industry
Sex: Male
Age: 20 Years – 45 Years
Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effect of atorvastatin on the pharmacokinetics of fimasartan.

Conditions

Essential Hypertension

Interventions

Type	Name	Description
DRUG	Atorvastatin
DRUG	Fimasartan

Timeline

Start date: 2009-07-01
Primary completion: 2009-09-01
Completion: 2009-09-01
First posted: 2009-10-08
Last updated: 2009-10-08

Source: ClinicalTrials.gov record NCT00991705. Inclusion in this directory is not an endorsement.